Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2022 | 1 |
2023 | 1 |
2024 | 0 |
Search Results
2 results
Results by year
Filters applied: . Clear all
Page 1
Net clinical benefit of oral anticoagulants in Korean atrial fibrillation patients with low to intermediate stroke risk: A report from the Clinical Survey on Stroke Prevention in patients with Atrial Fibrillation (CS-SPAF).
J Arrhythm. 2023 Mar 10;39(3):376-387. doi: 10.1002/joa3.12840. eCollection 2023 Jun.
J Arrhythm. 2023.
PMID: 37324774
Free PMC article.
BACKGROUND: The balance of stroke risk reduction and potential bleeding risk associated with antithrombotic treatment (ATT) remains unclear in atrial fibrillation (AF) at non-gender CHA(2)DS(2)-VASc scores 0-1. A net clinical benefit (NCB) analysis of ATT may guide stroke …
BACKGROUND: The balance of stroke risk reduction and potential bleeding risk associated with antithrombotic treatment (ATT) remains unclear …
Validation of Biomarker-Based ABCD Score in Atrial Fibrillation Patients with a Non-Gender CHA2DS2-VASc Score 0-1: A Korean Multi-Center Cohort.
Jung M, Byeon K, Kang KW, Park YM, Hwang YM, Lee SH, Jin ES, Roh SY, Kim JS, Ahn J, Lee SR, Choi EK, Ahn MS, Lee EM, Park HC, Lee KH, Kim M, Choi JH, Ko JS, Kim JB, Kim C, Lip GYH, Shin SY; Clinical Survey on Stroke Prevention in Patients with Atrial Fibrillation (CS-SPAF) Investigators.
Jung M, et al.
Yonsei Med J. 2022 Oct;63(10):892-901. doi: 10.3349/ymj.2022.0157.
Yonsei Med J. 2022.
PMID: 36168241
Free PMC article.
Item in Clipboard
Cite
Cite